Phase 1 Clinical Trials
The MEU is a UK leader in First in Man studies. We have considerable expertise in SAD and MAD trials. The emergence of hybrid designs, including patient cohorts, has allowed the MEU to provide a complete solution for clients seeking a single site solution for their Phase 1 programme.
Therapeutic Areas
The MEU is well-equipped to undertake large single centre early phase healthy volunteer clinical trials and specialist respiratory trials including Asthma, COPD, Cystic Fibrosis, Allergy, Dermatology, Inflammatory, Cardiovascular and Diabetes. Our ever-expansive portfolio facilitates the MEU to undertake Phase 1 studies in many other therapeutic areas.
Facilities
State-of-the-art, hospital-based facilities including 36 inpatient beds with cardiac and telemetry monitoring, a pharmacy, clinical assessment suite, bronchoscopy unit and numerous outpatient/consultant rooms.
Recruitment
Contact us today to sense-check your protocol synopsis against our ICARUS phenotyped database of over 17,000 clinical trial volunteers. We can run inclusion/exclusion criteria in minutes, instantly checking the phenotyped data across multiple therapeutic fields.
A leader in First-In-Patient studies for over twenty years
Latest News
MEU at the DIA Annual Meeting, San Diego June 2019
- Posted by The MEU
- On 23rd May 2019
MEU will be exhibiting at this year’s DIA Annual Meeting (23rd – 27th June 2019) held at the San Diego Convention Center,...
ECFS: 42nd European Cystic Fibrosis Conference
- Posted by The MEU
- On 23rd May 2019
Our Senior Physician, Dr Mat Khan, will be presenting a poster on behalf of the Medicines Evaluation Unit at the 42nd European...
DIA Europe 2019: 5th – 7th February, Vienna
- Posted by The MEU
- On 4th January 2019
DIA Europe is the biggest event in the European pharmaceutical calendar, with attendees gathering from across the globe to exhibit, partner and...